The combination of lumacaftor and ivacaftor (LUM/IVA) has been reported to induce a mean acute absolute drop of -4.1% predicted forced expiratory volume in 1s (FEV) after a unique administration in healthy subjects. The aim of the present study was to assess acute FEV changes after the first dose of LUM/IVA in CF patients. A total of 32 pediatric patients were included. Respiratory manifestations occurred in only 3 patients (9.4%), but FEV consistently decreased (-10.4±4.6%, range: -1.5; -21.8%). FEV only partially resumed after salbutamol inhalation. Patients with previously known significant reversible airway obstruction and low FEV were more at risk of FEV decrease.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.